Perrigo (PRGO) Accounts Payables (2013 - 2026)
Perrigo (PRGO) posted quarterly Accounts Payables of $434.8 million for Q1 2026, down 13.44% year-over-year from $502.3 million in Q1 2025, and down 8.37% quarter-over-quarter from $474.5 million in Q4 2025.
Perrigo (PRGO) Accounts Payables (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has reported Accounts Payables for 14 consecutive years, with $434.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Accounts Payables fell 13.44% year-over-year to $434.8 million; the TTM figure through Mar 2026 stood at $434.8 million (down 13.44% YoY), while the FY2025 annual figure was $474.5 million, down 4.18% from the prior year.
- Accounts Payables declined to $434.8 million in Q1 2026 per PRGO's latest filing, from $474.5 million in the prior quarter.
- Across five years, Accounts Payables topped out at $537.3 million in Q4 2022 and bottomed at $433.1 million in Q3 2023.
- Historically, Accounts Payables has averaged $476.7 million across 5 years, with a median of $474.5 million in 2025.
- Annual changes were most pronounced in 2022 — Accounts Payables soared 30.67% — and 2026, when it slipped 13.44%.
- Perrigo's Accounts Payables stood at $537.3 million in 2022, then slipped by 11.09% to $477.7 million in 2023, then climbed by 3.66% to $495.2 million in 2024, then slipped by 4.18% to $474.5 million in 2025, then fell by 8.37% to $434.8 million in 2026.
- Business Quant data shows PRGO's Accounts Payables at $434.8 million in Q1 2026, $474.5 million in Q4 2025, and $469.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 356.00 Mn |
| 10 | Perrigo | 1.91 Bn | 1.51 Bn | 313.90 Mn | 400.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 400.40 Mn |
| Mar 28, 2026 | 434.80 Mn |
| Dec 31, 2025 | 474.50 Mn |
| Sep 27, 2025 | 469.70 Mn |
| Jun 28, 2025 | 489.00 Mn |
| Mar 29, 2025 | 502.30 Mn |
| Dec 31, 2024 | 495.20 Mn |
| Sep 28, 2024 | 458.50 Mn |
| Jun 29, 2024 | 471.50 Mn |
| Mar 30, 2024 | 453.70 Mn |
| Dec 31, 2023 | 477.70 Mn |
| Sep 30, 2023 | 433.10 Mn |
| Jul 1, 2023 | 470.50 Mn |
| Apr 1, 2023 | 505.20 Mn |
| Dec 31, 2022 | 537.30 Mn |
| Oct 1, 2022 | 461.40 Mn |
| Jul 2, 2022 | 490.40 Mn |
| Apr 2, 2022 | 479.60 Mn |
| Dec 31, 2021 | 411.20 Mn |
| Oct 2, 2021 | 405.60 Mn |